MTNB - Matinas BioPharma Holdings - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $2.8. This is a potential upside of $2.2 (366.67%) from yesterday's end of day stock price of $0.6.

Matinas BioPharma Holdings's activity chart (see below) currently has 4 price targets and 8 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 1425 days.

Most recent stock forecast was given by YASMEEN RAHIMI from PIPER SANDLER on 13-Sep-2021. First documented stock forecast 27-Jan-2020.

Best performing analysts who are covering MTNB - Matinas BioPharma Holdings:

Yasmeen Rahimi Edward Tenthoff

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$4

3 years 2 months 21 days ago
(13-Sep-2021)

2/2 (100%)

$3.19 (393.83%)

1275

Hold

$2

3 years 6 months 23 days ago
(11-May-2021)

2/2 (100%)

$1.2 (150.00%)

1575

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MTNB (Matinas BioPharma Holdings) average time for price targets to be met?

On average it took 1425 days on average for the stock forecasts to be realized with a an average price target met ratio 100

Which analyst has the current highest performing score on MTNB (Matinas BioPharma Holdings) with a proven track record?

YASMEEN RAHIMI

Which analyst has the current lower performing score on MTNB (Matinas BioPharma Holdings) with a proven track record?

EDWARD TENTHOFF

Which analyst has the most public recommendations on MTNB (Matinas BioPharma Holdings)?

Yasmeen Rahimi works at PIPER SANDLER and has 4 price targets and 4 ratings on MTNB

Which analyst is the currently most bullish on MTNB (Matinas BioPharma Holdings)?

Yasmeen Rahimi with highest potential upside - $0

Which analyst is the currently most reserved on MTNB (Matinas BioPharma Holdings)?

Edward Tenthoff with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?